Search results
Supreme Court upholds FDA's approval of abortion pills for early pregnancies
LA Times via Yahoo News· 2 days ago"The plaintiffs have sincere legal, moral, ideological, and policy objections to elective abortion...
FDA warns consumers about paralytic shellfish poisoning in some contaminated shellfish
Consumer Affairs· 1 day agoThe U.S. Food and Drug Administration (FDA) has issued a warning to restaurants and retailers to put...
FDA panel votes unanimously for Eli Lilly's Alzheimer's treatment
Yahoo Finance· 5 days agoThe monoclonal antibody drug, delivered through an IV monthly for up to 18 months, would be the...
Legal Implications Following the FDA’s Release of Data on Talc-Containing Cosmetics, Which Confirm...
JD Supra· 1 day agoIn April, the U.S. Food and Drug Administration (FDA) released the results of its 2023 sampling assignment, testing for asbestos in talc-containing products ...
FDA asks COVID vaccine makers to target KP.2 strain with updated shots
Reuters· 18 hours agoThe U.S. Food and Drug Administration recommended COVID-19 vaccine makers target the KP.2 strain...
FDA Advisers Like Lilly’s Alzheimer’s Drug. It’s Good News for Biogen.
Barrons.com· 4 days agoThat is likely good news for Biogen and Eisai whose similar Alzheimer’s therapy will benefit from a...
FDA reverses course, calls for vaccines for fall 2024 to target newer COVID-19 strain
Scripps News via AOL· 19 hours agoThe FDA is reversing course on its COVID vaccine guidance: Rather than having a vaccine that targets...
FDA must fix “inadequate” inspection and recall policies, report says
Just Food via Yahoo Finance· 2 days agoThe complaint was sent electronically to the FDA but "not escalated to senior leadership due to a...
FDA took months to react to complaint about Abbott infant formula factory, audit finds
WSB Radio· 2 days agoThe Department of Labor received the email and three days later forwarded it to an FDA address...
FDA advises Covid vaccine makers to target KP.2 for fall shots
NBC NEWS· 2 days agoS. this winter. The announcement came just over a week after an FDA advisory panel voted unanimously...